Pain measurements and side effect profile of the novel cannabinoid ajulemic acid

@article{Salim2005PainMA,
  title={Pain measurements and side effect profile of the novel cannabinoid ajulemic acid},
  author={Kahlid Salim and Udo Schneider and Sumner H. Burstein and Ludwig Hoy and Matthias Karst},
  journal={Neuropharmacology},
  year={2005},
  volume={48},
  pages={1164-1171}
}
Preclinical findings on ajulemic acid (AJA) showed analgesic and anti-allodynic effects without psychoactive properties making it an appealing substance for the treatment of pain. A recently published randomized double-blind crossover clinical trial described the pain-reducing effects and side effect profile of AJA on 21 patients with chronic neuropathic pain. In this report from this same sample the effects of AJA on the mechanical hypersensitivity, on pain, and on psychological and physical… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS

4 Cannabinoids and Neuropathic Pain

VIEW 2 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Cannabinoide in der Schmerzmedizin

VIEW 1 EXCERPT
CITES BACKGROUND

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

  • Expert opinion on investigational drugs
  • 2014
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

EFNS guidelines on neuropathic pain assessment.

  • European journal of neurology
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Pharmacologic treatment of neuropathic pain.

  • Acta neurologica Belgica
  • 2001
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Neuropathic pain: new insights, new interventions.

  • Hospital practice
  • 1998
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Mechanosensation and pain.

  • Journal of neurobiology
  • 2004
VIEW 1 EXCERPT